H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Census population 301,578. Missouri Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed St. Louis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a St. Louis storefront.
Tendon and Ligament Support Therapy in St. Louis, MO for clinics & physicians. Biologic therapies for tend… Compliance support & pricing — contact Hawk Medical.
9.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Population 301,578. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and J5 documentation are ready before the first application of tendon ligament support therapy.
National Tendon and Ligament Support Therapy notes (how the product actually works)Three grains, kept separate on purpose. City: Census 301,578 and CDC PLACES crude rates. State: Missouri Department of Health & Senior Services, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and WPS Government Health Administrators LCDs. CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 13.2% of adults in St. Louis have diagnosed diabetes — 1.2 points above the U.S. 12% figure. Adult arthritis here is 24.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for St. Louis.
CDC PLACES (2023, crude prevalence) estimates 13.2% of adults — 1.2 points above the U.S. 12% figure. Obesity is 36.8%; arthritis is 24.2%. That is place-level BRFSS modeling, not a clinic census and not a St. Louis trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what J5 reviewers and surveyors expect — not a brochure.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. WPS Government Health Administrators LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
Bring specialty, monthly joint / regenerative volume, and whether you bill J5 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 13.2% diabetes and 24.2% arthritis for St. Louis — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in St. Louis, MO.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for St. Louis is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for St. Louis — 1.2 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Missouri Part B wound biologics follow this contractor (siblings: IA, KS, NE). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in St. Louis. Useful for joint-program math; still needs a diagnosis and privileging.
No St. Louis storefront. Joe Bradley is an active practice owner. tendon ligament support therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.